Condition
Ventricular Tachyarrhythmia
Total Trials
6
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed3
Recruiting1
Terminated1
Unknown1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06203262Not ApplicableRecruitingPrimary
Ventricular Catheter Ablation Study (VCAS)
NCT04024865CompletedPrimary
Domperidone and Risk of Serious Cardiac Events in Postpartum Women
NCT00858559Not ApplicableTerminated
Follow-up of Patients With Implantable Cardioverter Defibrillators by Home Monitoring (ANVITE)
NCT02303639Phase 4Unknown
Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias
NCT01282918Not ApplicableCompletedPrimary
NORDIC ICD (Cardioverter Defibrillator Implantation) Trial
NCT00701467CompletedPrimary
Change in Heart Rate Variability Prior to Tachyarrhythmia in ICD Implanted Patients
Showing all 6 trials